MedPath

Uroplasty, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:3

Trial Phases

3 Phases

Phase 1:1
Phase 4:3
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)โ€ข Click on a phase to view related trials

Phase 4
3 (60.0%)
Not Applicable
1 (20.0%)
Phase 1
1 (20.0%)

Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Phase 1
Terminated
Conditions
Fecal Incontinence
First Posted Date
2012-08-16
Last Posted Date
2015-10-29
Lead Sponsor
Uroplasty, Inc
Target Recruit Count
30
Registration Number
NCT01666405
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCSF Center for Colorectal Surgery, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Minnesota Colon and Rectal Surgery Associates, Ltd., Minneapolis, Minnesota, United States

and more 3 locations

Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence

Not Applicable
Conditions
Stress Urinary Incontinence
First Posted Date
2010-05-04
Last Posted Date
2020-03-11
Lead Sponsor
Uroplasty, Inc
Target Recruit Count
276
Registration Number
NCT01115465
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Urological Associates of Southern Arizona, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Kaiser Permanente Southern California-Irvine Medical Center, Irvine, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univeristy of California- Irvine, Orange, California, United States

and more 16 locations

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms

Phase 4
Completed
Conditions
Urinary Bladder, Overactive
First Posted Date
2009-06-26
Last Posted Date
2013-05-16
Lead Sponsor
Uroplasty, Inc
Target Recruit Count
50
Registration Number
NCT00928395
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Gregory L. Davis, M.D., FACOG, Inc., Chico, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Greenwich Urological Associates, P.C., Greenwich, Connecticut, United States

๐Ÿ‡บ๐Ÿ‡ธ

Specialists in Urology, Naples, Florida, United States

and more 9 locations

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

Phase 4
Completed
Conditions
Overactive Bladder
First Posted Date
2008-10-13
Last Posted Date
2012-04-18
Lead Sponsor
Uroplasty, Inc
Target Recruit Count
220
Registration Number
NCT00771264
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Gregory L. Davis, M.D., FACOG, Inc., Chico, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Greenwich Urological Associates, P.C., Greenwich, Connecticut, United States

๐Ÿ‡บ๐Ÿ‡ธ

Specialists in Urology, Naples, Florida, United States

and more 11 locations

Overactive Bladder Innovative Therapy Trial (OrBIT)

Phase 4
Completed
Conditions
Overactive Bladder
Interventions
Device: Urgent PC Neuromodulation System
First Posted Date
2007-03-16
Last Posted Date
2013-05-16
Lead Sponsor
Uroplasty, Inc
Target Recruit Count
100
Registration Number
NCT00448175
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Uroplasty, Inc, Minnetonka, Minnesota, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.